Accessed 5 Sep 2023
This allows them to spend resources on a single significant development program, for one optimal injection device, which then requires minimal customization for each subsequent product line. Despite efforts to make better, safer, simpler injection devices, patient adherence is still a challenge associated with self-administration
Limitless Life has demonstrated a strong commitment to product quality and safe peptide distribution, and they have fast, reliable shipping and a straightforward return process
In the Phase 3 ATTAIN-1 trial published in the New England Journal of Medicine in 2025, once-daily orforglipron produced mean body weight reductions of 7.5% (6 mg), 8.4% (12 mg), and 11.2% (36 mg) at 72 weeks, compared with 2.1% for placebo
Each works differently, and the best choice depends on your health goals and medical history
[8] In 2009, Topol worked with Gary and Mary West to create the West Wireless Health Institute, now called West Health Institute, to foster the use of digital tools in medical research and practice